1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
59.020.58(0.99%)
2.7M
XNAS Volume

XNAS 08 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Exelixis Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Exelixis Inc share price target, revenues, EPS, net income and more

Exelixis Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Exelixis Inc Jun-2026 Quarterly Revenue is $629 Million which is growth of 10.6% YoY.

  • POSITIVE

    Quarterly Net Profit Exelixis Inc Jun-2026 Quarterly Net Profit is $212 Million which is growth of 14.7% YoY.

Exelixis Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
628.7610.8598.7597.8568.3555.5566.8539.5637.2425.2479.7471.9469.9
Cost Of Rev.
20.72026.518.619.519.22017.317.721.321.818.817.7
Gross Profit
608590.9572.2579.2548.8536.3546.8522.2619.5404457.9453.2452.1
⌄
359.6339.5336.3322.8335.2349.4383.3334.4343.2341.7376.1470.7374.3
Operating Profit
248.4251.3235.9256.4213.6186.9163.5187.8276.462.381.8-17.677.9
14.216.117.415.916.819.121.318.717.319.921.423.122.5
Profit Before Tax
262.7267.7252.7252.4230.4205.7184.8154.8292.849.31035.8100.4
Tax
50.657.28.258.845.646.144.936.866.71217.54.819.2
⌄
212.1210.5244.5193.6184.9159.6139.9118226.137.385.5181.2
Diluted NI Avail to Com Stockholders Ann.
212.1210.5244.5193.6184.9159.6139.9118226.137.385.5181.2
Basic EPS
0.90.80.90.70.70.60.50.40.80.10.30.3
Diluted EPS After ExtraOrdinary
0.80.80.90.70.70.60.50.50.80.20.30.3
Number Of Shares End
250.8258.3266.5268.4272.6278.8284.5285.6289.2300.8308.5315.5324.2
Net Income Continuing Discontinued Operations
212.1210.5244.5193.6184.9159.6139.9118226.137.385.5181.2
Normalized Income
237.1232.8245.2208.8184.9159.6140.1157.4226.562.285.5181.2
Interest Income
14.216.117.415.916.819.121.318.717.319.921.423.122.5
Interest
-------------
Net Interest Income
14.216.117.415.916.819.121.318.717.319.921.423.122.5
EBIT
248.5251.6235.9256.4213.6186.9163.5187.8276.462.381.8-17.677.9
EBITDA
255.5258.5242.9263.8220.9194.2171.1195.3283.768.788.3-11.383.9
Reconciled Cost Of Rev.
20.72026.518.619.519.22017.317.721.321.818.817.7
Reconciled Depr.
7777.47.37.37.67.57.36.46.56.36
Profit From Continuing Operations
212.1210.5244.5193.6184.9159.6139.9118226.137.385.5181.2
Normalized EBITDA
255.4258.3243.6283.6220.9194.2171.4247.1284.2101.588.3-11.383.9
*All financials are in USD Million and price data in USD

Exelixis Inc competitor comparison and performance snapshot within industry

Exelixis Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue Exelixis Inc Dec-2025 Annual Revenue is $2,320 Million which is growth of 7.0% YoY.

  • POSITIVE

    Annual Net Profit Exelixis Inc Dec-2025 Annual Net Profit is $783 Million which is growth of 50.1% YoY.

Exelixis Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
12.9%
18.6%
 2,320.12,168.71,830.21,611.11,435987.5967.8853.8452.5191.537.2
Cost Of Rev. Ann.
13.1%
18.2%
85.783.776.272.657.952.936.333.126.415.16.63.9
Gross Profit Ann.
12.9%
18.6%
2,350.32,236.42,092.51,757.71,553.21,382.1951.3934.7827.5437.4184.933.3
Operating Exp. Ann.
-0.2%
9.8%
1,358.21,343.71,402.51,586.81,351.71,095.4841.2565.2388.6271.5212.1153.7
Operating Profit Ann.
64.2%
52%
992892.7690170.9201.5286.7110.1369.5438.9165.9-27.2-120.4
27.9%
28.3%
63.769.277.286.533.17.719.92812.8-3.8-28.2-48.3
Other Exp. Ann.
-
-
 -20.7-85.50.1-0.2-0.20.90.70.4-3.5-14.8-1
PBT Ann.
58.9%
48.4%
1,035.5941.2681.6257.5234.4294.2130.8398.1452.1158.6-70.2-169.7
Tax Ann.
44.9%
52.7%
174.8158.6160.449.852.163.119.177.1-2384.40.1
⌄
62.5%
47.6%
860.6782.6521.3207.8182.3231.1111.8321690.1153.9-70.2-169.7
Diluted NI Avail to Com Stockholders Ann.
62.5%
47.6%
860.6782.6521.3207.8182.3231.1111.8321690.1153.9-70.2-169.7
EPS Ann.
69.1%
48.6%
 2.91.80.70.60.70.41.12.30.5-0.3-0.8
Diluted EPS Ann.
67.1%
47.6%
 2.81.80.70.60.70.412.20.5-0.3-0.8
Number Of Shares End
-6.2%
-3%
 266.5284.5308.5323.3317.6310.8304.3298.5296288.1227.5
Total Exp. Ann.
0.4%
10.2%
 1,427.41,478.81,659.31,409.61,148.3877.5598.3415286.6218.7157.6
Net Income Continuing Discontinued Operations Ann.
62.5%
47.6%
860.6782.6521.3207.8182.3231.1111.8321690.1154.2-70.2-169.7
Normalized Income Ann.
63.7%
48.2%
923.8799.6586.6207.8182.3231.1111.8321690.1154.2-55.4-169.1
Interest Income Ann.
27.9%
28.3%
63.769.277.286.533.17.719.92812.84.94.90.4
Interest Ann.
-
-
 ------8.733.148.7
EBITDA Ann.
60.6%
50.5%
1,020.6921.8718.8196.6222.4300.3119.2406.5459.9168.4-36.2-119.6
Reconciled Cost Of Rev. Ann.
13.1%
18.2%
85.783.776.272.657.952.936.333.126.415.16.63.9
Reconciled Depr. Ann.
11.7%
26.2%
28.329.128.825.720.913.69.18.47.81.211.4
Profit From Continuing Operations Ann.
62.5%
47.6%
860.6782.6521.3207.8182.3231.1111.8321690.1154.2-70.2-169.7
Normalized EBITDA Ann.
61.8%
51.2%
1,040.8942.3804.1196.6222.4300.3119.2406.5459.9168.4-21.3-118.6
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
7%
2Y CAGR
12.6%
3Y CAGR
12.9%
5Y CAGR
18.6%
7Y CAGR
15.4%
10Y CAGR
51.2%
Total Revenue Annual growth is lower than historical averages.
Net Profit Ann.
1Y CHG
50.1%
2Y CAGR
94.1%
3Y CAGR
62.5%
5Y CAGR
47.6%
7Y CAGR
1.8%
Net Profit Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
-4.2%
2Y CAGR
-8%
3Y CAGR
-0.2%
5Y CAGR
9.8%
7Y CAGR
19.4%
10Y CAGR
24.2%
Operating Expenses Annual Cr is falling faster than historical averages.

Exelixis Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund Exelixis Inc Dec-2025 Total Shareholders Fund is $2,161 Million which is growth of -3.7% YoY.

  • NEGATIVE

    Total Assets Exelixis Inc Dec-2025 Total Assets is $2,844 Million which is growth of -3.5% YoY.

Exelixis Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-2.5%
5.9%
2,844.42,947.72,942.43,071.52,616.22,137.31,885.71,422.3655.3597.5332.3
⌄
5.4%
21.5%
683.1703.5678.5583.1405.6258.2199.7134.8370.3508.2436.7
⌄
-4.6%
2.8%
2,161.32,244.22,263.92,488.42,210.61,879.11,6861,287.528589.3-104.3
Total Capitalization Ann.
-4.6%
2.8%
2,161.32,244.22,263.92,488.42,210.61,879.11,6861,287.528589.3277.1
Tangible Assets Ann.
-4.7%
2.9%
2,097.62,180.52,200.22,424.72,146.91,815.41,622.31,223.8221.325.6-168
Working Capital Ann.
-7.1%
-3.5%
1,037.61,063.8923.71,294.41,497.21,240.7868.4791.5369.7200.2126.4
Invested Capital Ann.
-4.6%
2.8%
2,161.32,244.22,263.92,488.42,210.61,879.11,6861,287.5285278.4277.1
Tangible Book Value Ann.
-4.7%
2.9%
2,097.62,180.52,200.22,424.72,146.91,815.41,622.31,223.8221.325.6-168
Borrowings Ann.
-3.1%
28.6%
173190.8189.9190.251.349.150.712.2-189.1381.4
Net Debt Ann.
-
-
---------37.4239.8
Share Issued Ann.
-6.8%
-3.4%
262.5281.7302.8324318.8311.6304.8299.9296.2289.9228
Number Of Shares End
-6.2%
-3%
266.5284.5308.5323.3317.6310.8304.3298.5296288.1227.5
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
-3.5%
2Y CAGR
-1.7%
3Y CAGR
-2.5%
5Y CAGR
5.9%
7Y CAGR
10.4%
10Y CAGR
23.9%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
0.4%
2Y CAGR
1.4%
3Y CAGR
7.7%
5Y CAGR
14.7%
7Y CAGR
21.2%
10Y CAGR
22.7%
Total Current Liabilities Annual Cr growth is lower than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-3.7%
2Y CAGR
-2.3%
3Y CAGR
-4.6%
5Y CAGR
2.8%
7Y CAGR
7.7%
Total ShareHolders Funds Annual is falling faster than historical averages.

Exelixis Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • POSITIVE

    Book Value Per Share Exelixis Inc Book Value Per Share is $8 which is growth of 11.1% YoY.

  • NEUTRAL

    ROE Exelixis Inc ROE is 0% which is growth of 0% YoY.

Exelixis Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-17.70%6.91%6.41%9.72%5.56%19.41%66.43%24.56%-15.10%-51.41%
ROE Ann. %
-
-
-23.13%8.74%7.76%11.30%6.27%21.59%87.77%82.22%--
ROIC %
-
-
-5.12.7-1.74.31.43.73215.217.8-
OPM Ann. %
45.4%
28.1%
38.48%31.81%9.34%12.51%19.98%11.14%38.18%51.40%36.66%-14.21%-323.84%
Inventory Turnover Ratio Ann.
-
-
-3.82.91.92.22.12.93.232.21.6
Asset Turnover Ann. %
-
-
-0.70.60.60.60.50.60.80.70.40.1
Working Capital Turnover Ann.
22.4%
22.4%
2.2221.210.81.11.11.210.3
Quick Ratio Ann.
-
-
-3.43.14.75.26.76.88.34.11.73.3
Current Ratio Ann.
-
-
-3.63.355.47.17.18.54.21.73.4
Interest Coverage Ratio Ann.
-
-
--------19.3-1.1-2.5
LT Debt To Equity Ann.
-
-
-0.10.10.10000---
*All financials are in USD Million and price data in USD

Exelixis Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity Exelixis Inc Dec-2025 Cash From Operating Activity is $884 Million which is growth of 26.3% YoY.

  • POSITIVE

    Net Cash Flow Exelixis Inc Dec-2025 Net Cash Flow is $265 Million which is growth of 681.1% YoY.

Exelixis Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
34.6%
33.4%
884.3700333.3362.6400.8209527415.7165.6206.3-141.6
-
-
350.4-116.8-27-524.4-42.9-131.2-587.3-297.935.8-216.150.1
-
-
-969.6-628.8-546.10.6-14.8-25.112.69.7-169.919.8152.8
Cash Plus Cash Eqv. End Of Year Ann.
-1.4%
8.5%
482.5217.4263502.7663.9320.8268.1315.9183.2151.7141.6
Net Increase In Cash Plus Cash Eqv.s Ann.
-
38.2%
265.1-45.6-239.7-161.2343.152.6-47.7127.631.510.161.2
Cash Plus Cash Eqv. Begin Of Year Ann.
-31.1%
-4.1%
217.4263502.7663.9320.8268.1315.9188.3151.7141.680.4
Income Tax Paid Supplemental Data Ann.
6.7%
106.9%
155.3170.5185.7127.9134.17.910.70.50.20.2
Interest Paid Supplemental Data Ann.
-
-
------20.52119.8
Capex Ann.
-
-
-39.9-66.2-163-138.5-64.2-30.3-12.8-33.3-21.1-1.7-0.5
Issuance Of Capital Stock Ann.
-
-
--------145.7
Issuance Of Debt Ann.
-
-
-----------
Repayment Of Debt Ann.
-
-
-------0-185.8-7.7-4.4
Repurchase Of Capital Stock Ann.
-
-
-947.5-652-550.4--------
Free Cash Flow Ann.
55.6%
36.4%
844.3633.8170.4224.2336.6178.6514.1382.4144.5204.6-142
*All financials are in USD Million and price data in USD
Cash from Operating Act. Ann.
1Y CHG
26.3%
2Y CAGR
62.9%
3Y CAGR
34.6%
5Y CAGR
33.4%
7Y CAGR
11.4%
Cash from Operating Activity Annual growth is stable compared to historical averages.
Cash from Investing Act. Ann.
10Y CAGR
21.5%
Cash from Investing Activity Annual growth is higher than historical averages.